The company takes the technical innovation of molecular detection methods as the core driving force, and focuses on the R＆D and industrialization of molecular diagnostic products aiming at ...

Methods: Here, we employed a preclinical mouse model to study the adaptive humoral and cellular immune responses to a SARS-CoV-2 receptor binding domain (RBD) antigen formulated with ...

RNA was extracted from throat swab samples using the QIAamp Viral RNA Mini Kit (QIAGEN, Germantown, MD) according to the manufacturer’s instructions. Genomic copies of SARS-CoV-2 Nucleocapsid ...

To identify a candidate therapeutic antibody, researchers generally screen and test thousands of antibodies against an antigen target ... much of it is for SARS-CoV-2, flu and HIV - the algorithms ...

The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...

CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...

Subsequently, RNA from the barcoded cells was reverse-transcribed and sequencing libraries were prepared using Chromium Single-Cell 3’v3 Reagent Kit (10× Genomics ... when the patients were infected ...

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...